No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
MLTX250117C80000
- 0.35
- 0.000.00%
15min DelayTrading Jul 30 11:58 ET
0.00High0.00Low
0.00Open0.35Pre Close0 Volume15 Open Interest80.00Strike Price0.00Turnover98.45%IV52.41%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier24DDays to Expiry0.35Extrinsic Value100Contract SizeAmericanOptions Type0.0658Delta0.0096Gamma150.63Leverage Ratio-0.0351Theta0.0021Rho9.92Eff Leverage0.0174Vega
Intraday
- 5D
- Daily
News
MoonLake Immunotherapeutics Announces Board Changes and Incentives
Clear Street Launches Healthcare & Biotechnology Equity Research
Stifel Maintains MoonLake Immunotherapeutics(MLTX.US) With Buy Rating, Raises Target Price to $77
We Think MoonLake Immunotherapeutics (NASDAQ:MLTX) Can Afford To Drive Business Growth
Jefferies Maintains MoonLake Immunotherapeutics(MLTX.US) With Buy Rating, Maintains Target Price $65
LifeSci Capital Maintains MoonLake Immunotherapeutics(MLTX.US) With Buy Rating, Maintains Target Price $75